Evidence map›Paper›PMID 38361958›Full record

ArticleCurrent medical mycology2023

Jalal Jafarzadeh, Javad Javidnia, Seyed Ali Jeddi, Mahshid Vakili, Mojtaba Taghizadeh Armaki, Mahin Tavakoli

Open access · greenAbstract readCase Reports
In one paragraph

Article in Current medical mycology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Role ofCancer pathogenesis and therapy · 2025
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jalal JafarzadehDepartment of Medical Mycology and Parasitology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Javad JavidniaInvasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Seyed Ali JeddiDepartment of Laboratory Sciences, School of Allied Sciences, Abadan University of Medical Sciences, Abadan, Iran.
Mahshid VakiliDepartment of Bacteriology and Virology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Mojtaba Taghizadeh ArmakiInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Mahin TavakoliDepartments of Medical Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Babol University of Medical Sciences · IRMazandaran University of Medical Sciences · IRSemnan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: The COVID-19 pandemic may be an aggravating risk factor for the delay of the diagnoses of serious illnesses, such as oral squamous cell carcinoma, as well as poor management of patients with underlying morbidities, the onset of oral lesions, and antifungal susceptibility to opportunistic fungal infections. Oral candidiasis is one of the most common oral features of COVID-19. Case Report: This study aimed to report an 83-year-old female diagnosed with oral carcinoma who developed oropharyngeal candidiasis after falling ill with COVID-19. In late 2020, this patient was hospitalized for COVID-19 pneumonia. A fissured tongue with white scars appeared after the COVID-19 recovery that caused pain, dysphasia, and dysarthria. The sequencing result based on the internal transcribed spacer rDNA region confirmed Conclusion: Risk of fungal infections, such as

Indexed as

Candida glabrataCOVID-19Oropharyngeal candidiasisSquamous cell carcinoma

Identifiers

PMID38361958
PMCPMC10864745
OpenAlexW4394768298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.